[Peptide-lead drug discovery].
Oishi
Shinya
S
Fujii
Nobutaka
N
D000818:Animals; D019380:Anti-HIV Agents; D023181:Antimicrobial Cationic Peptides; D002454:Cell Differentiation; D054377:Chemokine CXCL12 / Q000502:physiology; D016503:Drug Delivery Systems; D015195:Drug Design; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D008024:Ligands; D015335:Molecular Probes; D008970:Molecular Weight; D009362:Neoplasm Metastasis; D010455:Peptides; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors / Q000502:physiology
D019380:Anti-HIV Agents; D023181:Antimicrobial Cationic Peptides; D054377:Chemokine CXCL12; D008024:Ligands; D015335:Molecular Probes; D010455:Peptides; D019718:Receptors, CXCR4; C062386:polyphemusin II